The FDA announced on June 27, 2012, that Hospira Inc. is recalling Paclitaxel Injection vials due to visible particles embedded in the glass neck of the vial. The agency said the particles may become dislodged into the solution.
How to tell if you have it
- Brand: Hospira
- Product: Paclitaxel Injection, 6 mg/mL, 50 mL Single Dose Vial
- NDC: 61703-342-50
- Lot numbers: Y096865AA (exp AUG 2013), Y106865AA (exp AUG 2013), Y116865AA (exp AUG 2013), Y126865AA (exp SEP 2013), Y136865AA (exp SEP 2013), Y146865AA (exp SEP 2013), Y156865AA (exp OCT 2013), Y166865AA (exp NOV 2013), Y176865AA (exp NOV 2013), and Y186865AA (exp DEC 2013)
- Quantity: 131,264 vials
- Distribution: Nationwide, including Puerto Rico and Guam; internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and Vietnam
The hazard
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (2026-07-24), Sun Pharmaceutical DOXOrubin Liposome Injection Recall (2026-05-12) and American Regent Epinephrine Injection Recall (2026-08-11).